Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Jamieson

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 2, 2023
Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing ProtocolAline Talhouk, Amy Jamieson, Emma J Crosbie, et al.
Human Pathology|September 4, 2025
Assessment of Nectin4-Expression in Vulvar Squamous Cell Carcinomas (VSCC): correlation with HPV-associated and HPV-independent Molecular SubtypesAnne Kathrin Höhn, Grit Gesine Ruth Hiller, Benjamin Wolf, et al.
Gynecologic Oncology|June 15, 2023
Harmonized molecular classification; assessment of a single-test ProMisE NGS toolAmy Jamieson, Melissa K McConechy, Amy Lum, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 21, 2025
Trop2 Expression in Correlation to the Molecular Subtype in Vulvar Squamous Cell CarcinomasAnne Kathrin Höhn, Benjamin Wolf, Mirjam Forberger, et al.
Histopathology|December 17, 2024
Papillary and ductal patterns of mesonephric-like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomasArdalan Akbari, Jennifer Pors, Amy Lum, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 13, 2022
Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinomaEmily F Thompson, Kathryn Shum, Richard W C Wong, et al.
Gynecologic Oncology|January 27, 2026
Substratification of mismatch repair deficient endometrial cancers based on mechanism of MMR loss can provide prognostic and predictive refinementAmy Jamieson, Sila Rogan, Allen W Zhang, et al.
Cancers|January 8, 2025
Molecular Subtypes of Vulvar Squamous Cell Carcinoma: The Significance of HPV-Independent/p53 Wild TypeLars-Christian Horn, Christine E Brambs, Blake Gilks, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 5, 2025
Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entityAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
Gynecologic Oncology|December 20, 2025
Prognostic value of perioperative circulating tumor DNA in endometrial cancer: systematic review & meta-analysisAmna Ahmed, Gagandeep Saini, Sarah E Ferguson, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 2, 2023
Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing ProtocolAline Talhouk, Amy Jamieson, Emma J Crosbie, et al.
Human Pathology|September 4, 2025
Assessment of Nectin4-Expression in Vulvar Squamous Cell Carcinomas (VSCC): correlation with HPV-associated and HPV-independent Molecular SubtypesAnne Kathrin Höhn, Grit Gesine Ruth Hiller, Benjamin Wolf, et al.
Gynecologic Oncology|June 15, 2023
Harmonized molecular classification; assessment of a single-test ProMisE NGS toolAmy Jamieson, Melissa K McConechy, Amy Lum, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 21, 2025
Trop2 Expression in Correlation to the Molecular Subtype in Vulvar Squamous Cell CarcinomasAnne Kathrin Höhn, Benjamin Wolf, Mirjam Forberger, et al.
Histopathology|December 17, 2024
Papillary and ductal patterns of mesonephric-like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomasArdalan Akbari, Jennifer Pors, Amy Lum, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 13, 2022
Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinomaEmily F Thompson, Kathryn Shum, Richard W C Wong, et al.
Gynecologic Oncology|January 27, 2026
Substratification of mismatch repair deficient endometrial cancers based on mechanism of MMR loss can provide prognostic and predictive refinementAmy Jamieson, Sila Rogan, Allen W Zhang, et al.
Cancers|January 8, 2025
Molecular Subtypes of Vulvar Squamous Cell Carcinoma: The Significance of HPV-Independent/p53 Wild TypeLars-Christian Horn, Christine E Brambs, Blake Gilks, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 5, 2025
Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entityAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
Gynecologic Oncology|December 20, 2025
Prognostic value of perioperative circulating tumor DNA in endometrial cancer: systematic review & meta-analysisAmna Ahmed, Gagandeep Saini, Sarah E Ferguson, et al.
Pageof 6